Federal Government Warns About Cannabis and Hemp in Drug Tests
Key Takeaway
Federal agencies issued updated warnings about the impact of medical cannabis and hemp product use on standard workplace drug testing protocols. The guidance came amid growing tension between state-legal marijuana programs and federal drug testing requirements for federally-regulated positions including commercial drivers, federal employees, and safety-sensitive industries. The guidance clarified that state-legal use does not provide a defense against positive federal drug tests, even in states where adult-use cannabis is fully legal. For cannabis operators, the guidance highlights ongoing employment and insurance complications for workers who consume cannabis, and reinforces the need for operator-funded employee assistance programs and clear workplace policies on off-duty use.
What This Means for Cannabis Businesses
Regulatory changes affect compliance requirements, licensing processes, and day-to-day operations for cannabis businesses. State-level rule changes can impact everything from product testing requirements to packaging standards to advertising restrictions. Operators should review their compliance procedures whenever new regulations take effect and work with consultants who specialize in their state's regulatory framework.
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
Maryland Lawmakers Pass Bill Protecting Firefighters Who Use Medical Cannabis Off Duty
New Congressional Research Report on Cannabis Rescheduling Published
Congressional Research Service Releases Comprehensive Cannabis Rescheduling Report
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.